Mega Genomics Limited (HKG:6667)

Mega Genomics Statistics

Total Valuation

Mega Genomics has a market cap or net worth of HKD 1.61 billion. The enterprise value is 1.11 billion.

Market Cap	1.61B
Enterprise Value	1.11B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Mega Genomics has 224.30 million shares outstanding.

Current Share Class	224.30M
Shares Outstanding	224.30M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+3.53%
Owned by Insiders (%)	18.45%
Owned by Institutions (%)	0.01%
Float	n/a

Valuation Ratios

The trailing PE ratio is 30.75.

PE Ratio	30.75
Forward PE	n/a
PS Ratio	9.24
PB Ratio	2.47
P/TBV Ratio	2.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	23.21
EV / Sales	6.37
EV / EBITDA	21.58
EV / EBIT	26.01
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.90, with a Debt / Equity ratio of 0.06.

Current Ratio	6.90
Quick Ratio	6.40
Debt / Equity	0.06
Debt / EBITDA	0.71
Debt / FCF	n/a
Interest Coverage	23.38

Financial Efficiency

Return on equity (ROE) is 7.15% and return on invested capital (ROIC) is 19.08%.

Return on Equity (ROE)	7.15%
Return on Assets (ROA)	3.27%
Return on Invested Capital (ROIC)	19.08%
Return on Capital Employed (ROCE)	6.20%
Weighted Average Cost of Capital (WACC)	9.59%
Revenue Per Employee	816,658
Profits Per Employee	223,998
Employee Count	214
Asset Turnover	0.21
Inventory Turnover	9.95

Taxes

In the past 12 months, Mega Genomics has paid 9.14 million in taxes.

Income Tax	9.14M
Effective Tax Rate	16.01%

Stock Price Statistics

The stock price has decreased by -28.14% in the last 52 weeks. The beta is 0.99, so Mega Genomics's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	-28.14%
50-Day Moving Average	7.96
200-Day Moving Average	8.51
Relative Strength Index (RSI)	46.97
Average Volume (20 Days)	21,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mega Genomics had revenue of HKD 174.76 million and earned 47.94 million in profits. Earnings per share was 0.23.

Revenue	174.76M
Gross Profit	127.01M
Operating Income	42.78M
Pretax Income	57.07M
Net Income	47.94M
EBITDA	51.56M
EBIT	42.78M
Earnings Per Share (EPS)	0.23

Balance Sheet

The company has 521.72 million in cash and 36.61 million in debt, with a net cash position of 485.11 million or 2.16 per share.

Cash & Cash Equivalents	521.72M
Total Debt	36.61M
Net Cash	485.11M
Net Cash Per Share	2.16
Equity (Book Value)	654.13M
Book Value Per Share	n/a
Working Capital	569.28M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 72.67%, with operating and profit margins of 24.48% and 27.43%.

Gross Margin	72.67%
Operating Margin	24.48%
Pretax Margin	32.66%
Profit Margin	27.43%
EBITDA Margin	29.50%
EBIT Margin	24.48%
FCF Margin	n/a

Dividends & Yields

Mega Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.69%
Shareholder Yield	4.69%
Earnings Yield	2.97%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6